U.S., May 17 -- ClinicalTrials.gov registry received information related to the study (NCT06976658) titled 'Glucokinase Activator in Monogenic Diabetes' on March 22.
Brief Summary: Evaluating a novel, allosteric glucokinase activator in monogenic diabetes secondary to inactivating glucokinase mutations: a randomised, cross-over trial
Study Start Date: May 28
Study Type: INTERVENTIONAL
Condition:
Diabetes Mellitus
Monogenic Diabetes
Intervention:
DRUG: Dorzagliatin
Dorzagliatin 50mg bd
DRUG: matched placebo
matched placebo
Recruitment Status: NOT_YET_RECRUITING
Sponsor: Chinese University of Hong Kong
Information provided by (Responsible Party): Elaine Chow, Chinese University of Hong Kong
Published by HT Digital Content Servic...